Emerging DeSci projects attract follow

Recently, a decentralized science project called GenomesDAO has gained the favor of well-known investment institutions. The project focuses on genomic data management and privacy protection, aiming to revolutionize the biotechnology field.

Overview of DeSci

Decentralized Science ( DeSci ) is an emerging field aimed at reforming the financing, collaboration, and intellectual property protection of research projects through Web3 technology. Although it has gained some recognition from institutions and industry professionals, DeSci's visibility among crypto users remains limited. However, considering its potential to revolutionize research methodologies, this field may experience significant development in the future.

Introduction to GenomesDAO

GenomesDAO was established in 2018 and is one of the early projects in the DeSci field. As a biotechnology DAO, it provides a secure and decentralized genomic testing platform and incentivizes users to participate through token rewards. In the current context where genetic data privacy is receiving increasing attention, the importance of GenomesDAO is becoming more pronounced.

The core concept of this project is to return control of genomic testing data to users. Unlike traditional models, GenomesDAO allows users to manage their own data and profit from it.

Operating Mechanism

The operational process of GenomesDAO is as follows:

1. Provide genetic testing services for users
2. Upload data to a secure DNA database, accessible only to users.
3. Third-party institutions can apply to use DNA data with platform tokens.
4. Users can choose whether to agree, and if they agree, they will receive platform tokens as a reward.

Users need to purchase a testing kit and submit samples. After completing the test, users will receive a unique NFT bound to their wallet to access their data.

Token Economics

The native token $GENOME of GenomesDAO has recently completed its chain migration. This token is not only used for data transactions but also to unlock disease test reports and participate in DAO governance. Holders can obtain voting rights and token rewards through staking.

Currently, the market capitalization of $GENOME is approximately 16.5 million USD, with a unit price of 0.0174 USD.

Future Outlook

GenomesDAO demonstrates multifaceted potential:

• Have actual products and revenue models
• Attractive narrative
• The development team continues to work hard
• There is still room for growth in market capitalization and trading volume.
• Recently received support from well-known investment institutions

The project team is actively collaborating with government and pharmaceutical companies to expand data mining opportunities. They also plan to attract users from traditional genetic testing companies through innovative strategies.

Despite the current low attention in the DeSci field, it may see significant development in the future as more investors begin to focus on it. For long-term investors, $GENOME may be a choice worth considering.